KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Other financing activities (2018 - 2025)

Guardant Health's Other financing activities history spans 8 years, with the latest figure at $21.8 million for Q4 2025.

  • For Q4 2025, Other financing activities changed N/A year-over-year to $21.8 million; the TTM value through Dec 2025 reached $24.6 million, changed N/A, while the annual FY2025 figure was $24.6 million, N/A changed from the prior year.
  • Other financing activities for Q4 2025 was $21.8 million at Guardant Health, up from -$9.5 million in the prior quarter.
  • Across five years, Other financing activities topped out at $21.8 million in Q4 2025 and bottomed at -$9.5 million in Q3 2025.
  • The 5-year median for Other financing activities is $118000.0 (2023), against an average of $1.9 million.
  • The largest YoY upside for Other financing activities was 4622.96% in 2025 against a maximum downside of 5325.41% in 2025.
  • A 5-year view of Other financing activities shows it stood at -$1.7 million in 2021, then skyrocketed by 98.95% to -$18000.0 in 2022, then soared by 755.56% to $118000.0 in 2023, then soared by 53.39% to $181000.0 in 2024, then soared by 11920.44% to $21.8 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Other financing activities are $21.8 million (Q4 2025), -$9.5 million (Q3 2025), and $151000.0 (Q2 2025).